The present invention comprises compounds of Formula I. wherein: R1, R2, R3, R5, A1, A2, and ? are defined in the specification. The invention also comprises a compound of Formula I for use in a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a compound for use in a method of modulating ROR?t activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.